Century Therapeutics

IPO

Engineering an Evolution in Cell Therapy

Public · Philadelphia, United States · Founded 2018 · $605.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$605.0M
Last Round
$135.0M Corporate RoundJan 2026
Rounds
4
Type
Public

About

Century Therapeutics is an innovative biotechnology company building an allogeneic iPSC-derived cell therapy platform for autoimmune diseases and cancer. The company integrates gene editing, protein engineering, and advanced manufacturing to develop off-the-shelf NK and T cell therapies. Century is led by industry veterans with decades of R&D and commercialization experience in cell therapy.

Summary

Century Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2018. It has raised $605.0M in total across 4 rounds, most recently a $135.0M Corporate Round round in Jan 2026. Investors include Leaps by Bayer, TCGX and Bain Capital Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundJan 2026
$135.0M

Sign up to see all 5 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Century Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/century-therapeutics"><img src="https://indexed.vc/api/badge/company/century-therapeutics" alt="Century Therapeutics on Indexed.vc" width="260" height="76" /></a>